On-demand stem cell mobilizer is an effective salvage strategy
Follow-up study confirms safety and tolerability of new treatment protocol
Study associates human CD38-targeting antibody with fewer complications
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy